PENTAMBODY Trademark

Trademark Overview


On Thursday, June 29, 2017, a trademark application was filed for PENTAMBODY with the United States Patent and Trademark Office. The USPTO has given the PENTAMBODY trademark a serial number of 79225073. The federal status of this trademark filing is REGISTERED as of Tuesday, November 5, 2019. This trademark is owned by BEIJING HANMI PHARMACEUTICAL CO., LTD.. The PENTAMBODY trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes, pharmaceutical preparations, drugs for medical purposes, biological preparations for medical purposes, biochemical drugs, and pharmaceutical preparations in the form of injection, each of which being, namely, for treating one or more of autoimmune diseases, immune response against grafts, allergic reactions, neurodegenerative diseases, neoplastic diseases and cellular proliferative disorders, arthritis, rheumatoid arthritis, psoriasis, multiple sclerosis (MS), ulcerative colitis, Crohn's disease, systemic lupus erythematosus (SLE), glomerulonephritis, dilated cardiomyopathy-like diseases, Sjogren's syndrome, allergic contact dermatitis, polymyositis, scleroderma, periarteritis nodosa, rheumatic fever, vitiligo, insulin-dependent diabetes mellitus, Behcet's syndrome, chronic thyroiditis, Parkinson's disease, Huntington's disease, Machado-Joseph disease, amyotrophic lateral sclerosis (ALS), Creutzfeldt - Jakob disease, leukemia, lymphoma, myeloma, brain tumo...
pentambody

General Information


Serial Number79225073
Word MarkPENTAMBODY
Filing DateThursday, June 29, 2017
Status700 - REGISTERED
Status DateTuesday, November 5, 2019
Registration Number5899437
Registration DateTuesday, November 5, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 20, 2019

Trademark Statements


Goods and ServicesMedicines for human purposes, pharmaceutical preparations, drugs for medical purposes, biological preparations for medical purposes, biochemical drugs, and pharmaceutical preparations in the form of injection, each of which being, namely, for treating one or more of autoimmune diseases, immune response against grafts, allergic reactions, neurodegenerative diseases, neoplastic diseases and cellular proliferative disorders, arthritis, rheumatoid arthritis, psoriasis, multiple sclerosis (MS), ulcerative colitis, Crohn's disease, systemic lupus erythematosus (SLE), glomerulonephritis, dilated cardiomyopathy-like diseases, Sjogren's syndrome, allergic contact dermatitis, polymyositis, scleroderma, periarteritis nodosa, rheumatic fever, vitiligo, insulin-dependent diabetes mellitus, Behcet's syndrome, chronic thyroiditis, Parkinson's disease, Huntington's disease, Machado-Joseph disease, amyotrophic lateral sclerosis (ALS), Creutzfeldt - Jakob disease, leukemia, lymphoma, myeloma, brain tumors, head and neck squamous cell carcinoma, non-small cell lung cancer (NSCLC), nasopharyngeal cancer, esophageal cancer, stomach cancer, pancreatic cancer, gallbladder cancer, liver cancer, colorectal cancer, breast cancer, ovarian cancer, cervical cancer, endometrial cancer, uterine sarcoma, prostate cancer, bladder cancer, renal cell carcinoma, melanoma, and combinations thereof; nutritional supplements and dietetic substances adapted for medical use, namely, dietetic foods adapted for medical use and dietetic beverages adapted for medical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 19, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBEIJING HANMI PHARMACEUTICAL CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBeijing
CN

Party NameBEIJING HANMI PHARMACEUTICAL CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBeijing
CN

Party NameBEIJING HANMI PHARMACEUTICAL CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBeijing
CN

Trademark Events


Event DateEvent Description
Friday, April 24, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, March 2, 2020GENERIC MADRID TRANSACTION SENT TO IB
Monday, March 2, 2020GENERIC MADRID TRANSACTION CREATED
Wednesday, February 5, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 5, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, August 20, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 20, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 31, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 31, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 31, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 18, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 5, 2019NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, June 20, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 20, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 19, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 19, 2019NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, June 17, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, June 17, 2019EX PARTE APPEAL-INSTITUTED
Monday, June 17, 2019JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, June 17, 2019EXPARTE APPEAL RECEIVED AT TTAB
Monday, December 17, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, December 17, 2018FINAL REFUSAL E-MAILED
Monday, December 17, 2018FINAL REFUSAL WRITTEN
Wednesday, November 14, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 14, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 14, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, November 9, 2018ASSIGNED TO LIE
Tuesday, October 30, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 31, 2018NOTICE OF REVIVAL - MAILED
Tuesday, October 30, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 30, 2018PETITION TO REVIVE-GRANTED
Tuesday, October 30, 2018TEAS PETITION TO REVIVE RECEIVED
Monday, October 1, 2018ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, October 1, 2018ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Saturday, February 24, 2018REFUSAL PROCESSED BY IB
Saturday, February 3, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, February 2, 2018REFUSAL PROCESSED BY MPU
Monday, January 29, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, January 28, 2018NON-FINAL ACTION WRITTEN
Tuesday, January 23, 2018APPLICATION FILING RECEIPT MAILED
Friday, January 19, 2018ASSIGNED TO EXAMINER
Friday, January 19, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 18, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB